VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 56 filers reported holding VENTYX BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,274,802 | +2.3% | 1,706,784 | -3.4% | 0.04% | +8.3% |
| Q2 2023 | $57,926,849 | +8.2% | 1,766,307 | +10.5% | 0.04% | +2.9% |
| Q1 2023 | $53,534,654 | +11.6% | 1,598,416 | +9.2% | 0.04% | +2.9% |
| Q4 2022 | $47,985,346 | +4.5% | 1,463,772 | -44.3% | 0.03% | 0.0% |
| Q3 2022 | $45,933,888 | +97.2% | 2,629,078 | +38.0% | 0.03% | +112.5% |
| Q2 2022 | $23,296,000 | -17.4% | 1,905,247 | -10.7% | 0.02% | +14.3% |
| Q1 2022 | $28,202,000 | -30.9% | 2,133,854 | -1.5% | 0.01% | -17.6% |
| Q4 2021 | $40,816,000 | – | 2,166,532 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |